33557283|t|Potential Role of Melatonin as an Adjuvant for Atherosclerotic Carotid Arterial Stenosis.
33557283|a|Carotid artery stenosis (CAS) is an atherosclerotic disease characterized by a narrowing of the artery lumen and a high risk of ischemic stroke. Risk factors of atherosclerosis, including smoking, hypertension, hyperglycemia, hyperlipidemia, aging, and disrupted circadian rhythm, may potentiate atherosclerosis in the carotid artery and further reduce the arterial lumen. Ischemic stroke due to severe CAS and cerebral ischemic/reperfusion (I/R) injury after the revascularization of CAS also adversely affect clinical outcomes. Melatonin is a pluripotent agent with potent anti-inflammatory, anti-oxidative, and neuroprotective properties. Although there is a shortage of direct clinical evidence demonstrating the benefits of melatonin in CAS patients, previous studies have shown that melatonin may be beneficial for patients with CAS in terms of reducing endothelial damage, stabilizing arterial plaque, mitigating the harm from CAS-related ischemic stroke and cerebral I/R injury, and alleviating the adverse effects of the related risk factors. Additional pre-clinical and clinical are required to confirm this speculation.
33557283	18	27	Melatonin	Chemical	MESH:D008550
33557283	47	88	Atherosclerotic Carotid Arterial Stenosis	Disease	MESH:D016893
33557283	90	113	Carotid artery stenosis	Disease	MESH:D016893
33557283	115	118	CAS	Disease	MESH:D016893
33557283	126	149	atherosclerotic disease	Disease	MESH:D050197
33557283	218	233	ischemic stroke	Disease	MESH:D002544
33557283	251	266	atherosclerosis	Disease	MESH:D050197
33557283	287	299	hypertension	Disease	MESH:D006973
33557283	301	314	hyperglycemia	Disease	MESH:D006943
33557283	316	330	hyperlipidemia	Disease	MESH:D006949
33557283	353	362	circadian	Disease	MESH:D021081
33557283	386	401	atherosclerosis	Disease	MESH:D050197
33557283	463	478	Ischemic stroke	Disease	MESH:D002544
33557283	493	496	CAS	Disease	MESH:D016893
33557283	501	543	cerebral ischemic/reperfusion (I/R) injury	Disease	MESH:D015428
33557283	575	578	CAS	Disease	MESH:D016893
33557283	620	629	Melatonin	Chemical	MESH:D008550
33557283	670	682	inflammatory	Disease	MESH:D007249
33557283	819	828	melatonin	Chemical	MESH:D008550
33557283	832	835	CAS	Disease	MESH:D016893
33557283	836	844	patients	Species	9606
33557283	879	888	melatonin	Chemical	MESH:D008550
33557283	911	919	patients	Species	9606
33557283	925	928	CAS	Disease	MESH:D016893
33557283	1024	1027	CAS	Disease	MESH:D016893
33557283	1036	1051	ischemic stroke	Disease	MESH:D002544
33557283	1056	1075	cerebral I/R injury	Disease	MESH:D015428
33557283	Negative_Correlation	MESH:D008550	MESH:D002544
33557283	Negative_Correlation	MESH:D008550	MESH:D015428
33557283	Negative_Correlation	MESH:D008550	MESH:D016893
33557283	Association	MESH:D008550	MESH:D050197
33557283	Negative_Correlation	MESH:D008550	MESH:D007249

